CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 2,092 shares at $45.69 ($95,583)
- 4 Open-market sale EVP, Strategy & Innovation sold 7,137 shares at an average $46.28 ($330,290)
- 4 Open-market sale Director sold 13,000 shares at an average $46.28 ($601,615)
- 4 Other disposition EVP, Strategy & Innovation disposed of 8,398 shares (other)
- 4 Option exercise Director acquired 4,320 shares (option exercise)
- 4/A Open-market sale Director sold 7,598 shares at $41.05 ($311,898)
- 4 Open-market sale Director sold 18,978 shares at an average $39.99 ($758,983)
- 4 Open-market sale Director sold 25,000 shares at $38.70 ($967,500)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 19 · 370 filings